key: cord-0845149-vw6hpd40
authors: Wu, Honghan; Zhang, Huayu; Karwath, Andreas; Ibrahim, Zina; Shi, Ting; Zhang, Xin; Wang, Kun; Sun, Jiaxing; Dhaliwal, Kevin; Bean, Daniel; Cardoso, Victor Roth; Li, Kezhi; Teo, James T; Banerjee, Amitava; Gao-Smith, Fang; Whitehouse, Tony; Veenith, Tonny; Gkoutos, Georgios V; Wu, Xiaodong; Dobson, Richard; Guthrie, Bruce
title: Ensemble learning for poor prognosis predictions: a case study on SARS-CoV2
date: 2020-11-13
journal: J Am Med Inform Assoc
DOI: 10.1093/jamia/ocaa295
sha: 5aa6ec94423f21da4d6fa2aa9ac430cc683dc05a
doc_id: 845149
cord_uid: vw6hpd40

OBJECTIVE: Risk prediction models are widely used to inform evidence-based clinical decision making. However, few models developed from single cohorts can perform consistently well at population level where diverse prognoses exist (such as the SARS-CoV2 pandemic). This study aims at tackling this challenge by synergising prediction models from the literature using ensemble learning. MATERIALS AND METHODS: In this study we selected and reimplemented seven prediction models for COVID-19, which were derived from diverse cohorts and used different implementation techniques. A novel ensemble learning framework was proposed to synergise them for realising personalised predictions for individual patients. Four diverse international cohorts (2 from the UK and 2 from China; total N=5,394) were used to validate all eight models on discrimination, calibration and clinical usefulness. RESULTS: Results showed that individual prediction models could perform well on some cohorts while poorly on others. Conversely, the ensemble model achieved the best performances consistently on all metrics quantifying discrimination, calibration and clinical usefulness. Performance disparities were observed in cohorts from the two countries: all models achieved better performances on the China cohorts. DISCUSSION: When individual models were learned from complementary cohorts, the synergised model will have the potential to achieve synergised performances. Results indicate that blood parameters and physiological measurements might have better predictive powers when collected early, which remains to be confirmed by further studies. CONCLUSIONS: Combining a diverse set of individual prediction models, ensemble method can synergise a robust and well-performing model by choosing the most competent ones for individual patients.

Risk prediction models are widely used in clinical practice to inform decision making. [1] [2] [3] Good models cannot only improve health service efficiencies but also predict deterioration [4] in a proactive manner [5] , with a great potential to improve outcomes and save lives. Such evidence based decision making supports are particularly important in an epidemic or pandemic outbreak, not only for informing the treatments/managements of those infected but also for optimising healthcare services to minimise indirect effects to most vulnerable service users. For example, the recent SARS-CoV2 has caused substantial excess mortality [6, 7] at least partly due to an indirect effect upon healthcare systems leading to a loss of capacity to provide elective and emergency care within the "golden window" of opportunity [7] [8] [9] . To mitigate excess mortality, more targeted inpatient care in future waves could be informed by (a) better risk prediction and (b) insights from international COVID-19 (we use SARS-CoV2 and COVID-19 interchangeably) datasets and experience to validate models and learn from different countries' responses.

There have been numerous prediction models developed for COVID-19, [10] [11] [12] [13] [14] but most were derived in small datasets, had low methodological quality and are unvalidated. [13] In addition, models learned from single cohorts (even from several centres) might not have the predictive power to achieve good performance in situations where a disease spreads to the whole population, leading to greatly diverse prognoses. In this study, we reproduced various prediction models with reasonable quality and synergised them using ensemble learning [15] to assess their collective ability to accurately discriminate mild and severe patients in a diverse set of four patient cohorts from the UK and China with varying patterns of disease severity (Figure 1a ). In particular, China and the UK had very different approaches to hospital admission for COVID-19.

In Wuhan, admission was routine with patients triaged to low intensity (Fangcang hospitals [16]) or higher dependency (designated hospitals) settings, whereas in the UK, admission of patients with more severe disease or at perceived higher risk of severe disease was prioritised. These differences enabled us to assess model performance in different settings. For outcomes specifically, we primarily focused on poor prognosis defined by either death or intensive care unit (ICU) stay. Figure 2 depicts the architecture of this work -synergising individual models from the literature for preventing excess mortality. For prediction models (Figure 1b) , seven models (Dong, [10] Shi, [17] Gong, [18] Lu, [19] Yan, [20] Xie, [21] and Levy [22] ) were chosen with different model types using diverse sets of predictors. Derivation cohorts were diverse, originating from six regions in two countries, with median ages ranging from 44-65 years, and with mortality varying between 7-52%. Such diversity provides leverage for synergising insights from these derivation cohorts to obtain a collective, and hopefully improved predictive power.

To synergise models derived from multinational datasets, we used ensemble learning, [15,23] a machine learning methodology which is particularly effective when single models perform well at certain subsets of the whole data samples but none of them can achieve good overall performances. The rationale is to partition the data samples into groups and choose the most suitable model(s) for particular groups (e.g. to give more weights to models derived from older populations with more severe cases for a 78-year-old patient with lymphocyte count of 0.7) so that the optimal overall prediction result can be achieved. Figure 1c shows a synthetic and schematic illustration of such a situation. In (conventional) ensemble learning scenarios, weak predictors are usually trained on subsets of the same dataset. The key difference of this work is that the weak predictors were not trained locally on one particular dataset but selected from the literature, i.e. learned from external datasets (which the ensemble model does not have access to) and re-implemented for aggregation.

The aggregation approaches used in this study do not belong to the stacking method (also called stacked generalization [24] ) that is to learn a new model using inputs from individual classifiers. Instead, they are inspired by bagging predictors [25] -aggregating results in a dataindependence manner.

The first Wuhan cohort (Wuhan01) consisted of 2,869 adults with COVID-19 confirmed by RT-PCR admitted to one of two hospitals in Wuhan, China (Wuhan Sixth Hospital and Taikang Tongji Hospital), admitted between 01/02/2020 and 23/02/2020, and who died or were discharged on or before 29/03/2020. The second Wuhan cohort (Wuhan02) consisted of 357 adults with COVID-19 from Tongji Hospital, data of which was collected between 10/01/2020 and 04/03/2020. respectively. The large difference in mortality between two Wuhan cohorts was possibly because: (a) Wuhan02 admitted more severe cases under Wuhan city-wide coordination [20] ;

(b) the two were followed up in different periods related to the surge (Figure 1a .2). Table 1 gives the baseline for comparing poor-prognosis/died and not-poor-prognosis/did-not-die subgroups of all 4 cohorts. All cohorts were retrospective and extracted from Electronic Health Records for this study. Demographics and baselines of all four validation cohorts are described in detail in supplementary material (Table S2 -S5).

In May 2020, we conducted a literature search for COVID-19 poor prognosis models. The search and selection process are described with details in supplementary material Figure S1 .

Briefly, for prediction models (Figure 1b) , we selected COVID-19 prognosis (either death or severity) models that were (a) reproducible (implementable models with all parameters reported); (b) using predictors that are readily available at community triage at large scale ( i.e. demographics, underlying conditions, blood tests, and vital signs); (c) with sufficient information describing the derivation cohort including cohort size, interquartile range (IQR) of age, country/region, follow-up period and mortality/poor-prognosis ratios. Table 2 describes information of the seven models including the outcomes, computational methods, information of derivation cohorts (size, region/country, mortality rate, follow-up period etc).

We re-implemented these seven prediction models by extracting all parameters from their published/preprint manuscripts or public-facing websites. 5 different models are implemented including decision tree, logistic regression, nomogram, scoring, and NOCOS (a customised transparent model). We also extracted derivation cohort size, follow-up periods, and distributions of numeric predictors (bloods and vitals). Supplementary Table S1 shows predictors used by each prediction model and also gives the numeric variable distributions of their derivation cohorts. Figure 1b illustrates the timeline of the follow-up periods of all models' derivation cohorts.

Competence assessment framework for model selection

The key to obtaining an effective ensemble model is a good aggregation mechanism that can choose the best performing model(s) for individual patients so that an overall optimal classification could be achieved. Stacking methods (learning a model from individual classifiers) usually produce better ensembles than bagging (majority vote or weighted majority vote). [23] However, the former requires labelled data to further learn a model, which is not possible in our scenario -using the ensemble model in clinical decision makings for managing COVID-19.

Therefore, a data-independent approach (like bagging) is required. For risk prediction models, their predictive capacities are underpinned by the patient characteristics of their derivation cohorts. For example, given a new patient, models that were trained on (enough number of) similar patients likely perform better than those were not. The conventional bagging methods (majority vote or their variations) are unlikely to work very well as they are not capable of capturing such a similarity and its associations with model competence.

We propose a novel bagging mechanism using a competence assessment framework for assisting model selections in the aggregation step. The framework is designed to quantify the competence of each model for a given patient data sample. Three factors are considered. The first factor is called familiarity competence, which quantifies the above-mentioned similarity, i.e., how familiar is a model with the new patient sample to be predicted. The second factor is the general competence which can be reflected by the derivation cohort size as we know prediction models derived from large cohorts are usually superior to those from smaller ones. The final factor is to consider data completeness of a patient sample relative to a prediction model. 'Absolute' data completeness of our validation cohorts is observed to be relatively good, meaning if a clinical feature is collected at a hospital most patients tend to have it. However, 'relative' completeness (i.e., given a prediction model, the percentage of its risk predictors available in the dataset) varies significantly. Model predictive powers are likely to be compromised by such relative incompleteness, which therefore needs to be considered in the framework.

We first specify the calculation of the familiarity competence. Let be the set of all numeric predictors, be the distribution (median, 1st quartile and 3rd quartile respectively) of in the model 's derivation cohort. Given a patient data sample:

, the familiarity competence of on is defined as follows.

The final competence calculation is defined as the formula below. The first component divides the familiarity competence by the total number of numeric predictors of the model, incorporating the relative data completeness of to . The second component is general competence based on the size of a model's derivation cohort. Assuming the two components are equally important, we calculate the overall competence as a sum of the two.

Different methods have been proposed in multiple classifier systems [26] A set of fusion methods were implemented. For competence-independent ones, we implemented voting (majority, one positive, and one negative) and scoring (maximum and average), which are common fusion strategies used in ensemble learning [26] . When all models are assessed against the data of a given patient, the competence values can then be used to fuse predictions (probabilities of poor-prognosis) from all models. We implemented trust-themost-competent mode: use the prediction of the one with highest competence value; wisdom-ofthe-crowd mode: use the weighted average of all predictions; highest-in-top-competent-ones:

use the maxim probability in top k competent models (k=3, 5). Supplementary Figure S2 gives an illustrative example of the three fusion strategies. Wisdom-of-the-crowd performed the best in our experiments and was used in this work.

The original model design is another factor that needs to be considered in the prediction fusion.

Individual models were designed for predicting different severities: mortality or different definitions of severities. We manually defined a severity score for each model (death models:

1.0; poor prognosis ones: 0.3) and combined those scores in the final fusion formula as follows.

The formula considers predictions from all individual models and combines them as weighted average.

The performances of prediction models were evaluated on three aspects: discrimination ( For clinical usefulness, we focus on decision-making support for admission strategies (i.e., who to admit and to where). It is not appropriate to use a fixed threshold of probability to validate model performances as (a) individual models are derived from cohorts with diverse severities and on slightly different definitions of poor prognosis; (b) severity in the validation cohorts also varies significantly. Instead, for each validation cohort we compute an event-rate (number of poor-prognosis/deceased patients divided by total number of patients) and for models we compute a prediction rate (predicted events divided by total number of patients). We then validate the sensitivity and specificity of a model when its prediction rate is closest to 1.5 times of the event rate or a minimal ratio of 0.15, whichever is larger. Figure 3b shows the performances of all models on 4 cohorts using cohort-specific prediction rate. We observed the ensemble model consistently outperforms individual models across all cohorts on positive predictive value (PPV), sensitivity and specificity. We observed prediction rate based cut-offs led to quite different performances on the metrics of PPV, sensitivity and specificity. These were what we expected. For example, for Wuhan01, the mortality rate is 2.4%, which is close to the population level. Therefore, we would expect a good model to have high specificity (ensemble model achieved 0.88) to correctly reject less severe patients so that hospital capacity can be mostly reserved for likely-to-deteriorate patients (without admitting too many mild patients). On the contrary, when the cohort is very severe (e.g. Wuhan02), high sensitivity is preferred (ensemble model: 0.96) as we don't want to discharge those who would likely need intensive care.

To quantify how well the ensemble model reclassifies patients, we also calculated the net reclassification improvements [28] by comparing it to the best individual model on each validation cohort. Table 3 gives the details, where the ensemble model achieved net improvements in all cases with the biggest on Wuhan02 and the smallest on KCH.

We also evaluated the model calibrations of all models on all four cohorts: Figure 3c shows the calibration slope and calibration-in-large, and Figure S3 depicts the calibration plots. For individual models, similar to C-index performances, they did not perform consistently well across cohorts. For example, Xie had very good calibration on Wuhan01 while it performed poorly on UHB. Again, the ensemble model has shown robust performances on all cohorts -calibrations were good to very good generally.

This work has shown that single models for prediction did not consistently perform well. Therefore, they are unlikely to achieve a high performance in external cohorts when there are many patients with novel characteristics. On the other hand, ensemble learning methods have the potential to make the best use of all available models. If these models were learned from complementary cohorts, the synergised model will have the potential to achieve better performances than any single model by using most competent ones for individual patients.

Comparing results in the UK (patients being admitted with more severe disease) and Chinese cohorts (more patients being admitted with mild disease), all models consistently performed worse on UK cohorts. Considering the fact that individual models used quite diverse predictors, adopted different computational algorithms and were derived from different regions/countries, it seems the observed poorer performances are likely associated with the UK's response to the first wave of COVID-19 surge. The UK mainly admitted severe patients aiming to reserve health service capacities. Therefore, one possible explanation is that blood parameters and physiological measurements are better collected as early as possible to contribute to improved predictive utility.

One limitation of this work was that we were unable to include prediction models that were learned from European cohorts, particularly from the UK. Including more local models would probably facilitate the ensemble framework to identify those predictors that are more predictive in the European cohorts, which would in turn improve the overall performance in the UK cohorts.

In our future work, we will create a web platform to allow the community to share models so that a wide range of diverse and complementary models can be synergised.

In this study we selected and reimplemented seven prediction models for 

Validation results of discrimination, clinical usefulness and calibration. a, discrimination performances: median (95%CI). b, positive predictive value (PPV), sensitivity and specificity of all models validated on cohort-specific prediction rate. Models that could not achieve expected prediction rates were excluded. c, calibration results on four validation cohorts: median (95%CI) where empty cells are for those models which were not validated because they were derived from the same hospital data. 

Risk prediction models for hospital readmission: a systematic review

Comparisons of established risk prediction models for cardiovascular disease: systematic review

Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review

Multicenter Comparison of Machine Learning Methods and Conventional Regression for Predicting Clinical Deterioration on the Wards

Failure of CRP decline within three days of hospitalization is associated with poor prognosis of Community-acquired Pneumonia

Excess Deaths From COVID-19 and Other Causes

Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study

Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency

Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic

Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score

Evaluation and Improvement of the National Early Warning Score (NEWS2) for COVID-19: a multi-hospital study

Risk Prediction for Poor Outcome and Death in Hospital In-Patients with COVID-19: Derivation in Wuhan, China and External Validation in London

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal

Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: An observational cohort study

Fangcang shelter hospitals: a novel concept for responding to public health emergencies

Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan

A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, China

ACP Risk Grade: A Simple Mortality Index for Patients with Confirmed or Suspected Severe Acute Respiratory Syndrome Coronavirus 2 Disease (COVID-19) During the Early Stage of Outbreak in Wuhan

An interpretable mortality prediction model for COVID-19 patients

Development and external validation of a prognostic multivariable model on admission for hospitalized patients with COVID-19

Development and Validation of a Survival Calculator for Hospitalized Patients with COVID-19. medRxiv Published Online First: 27

Ensemble Machine Learning: Methods and Applications

Stacked generalization

Bagging predictors

Combining Pattern Classifiers: Methods and Algorithms

Net Reclassification Improvement: Computation, Interpretation, and Controversies